{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:31:15Z","timestamp":1792499475564,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejps.2025.107109","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:45:22Z","timestamp":1745376322000},"page":"107109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Enhanced pulmonary delivery of spray-dried theophylline: investigation of the trehalose and amino acid combinations as innovative fine carriers"],"prefix":"10.1016","volume":"209","author":[{"given":"Lomass","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Party","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Par\u00f3czai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Buri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ambrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107109_bib0001","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2019.04.018","article-title":"Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler","volume":"134","author":"Abadelah","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16050680","article-title":"Spray-dried nanolipid powders for pulmonary drug delivery: a comprehensive mini review","volume":"16","author":"Abu Elella","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1208\/s12249-012-9883-3","article-title":"Theophylline cocrystals prepared by spray drying: physicochemical properties and aerosolization performance","volume":"14","author":"Alhalaweh","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107109_bib0004","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1023\/A:1018805232453","article-title":"The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody1","volume":"16","author":"Andya","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.apt.2023.104152","article-title":"Screening of sugars and cyclodextrins as carriers in montelukast dry powder inhalers processed by spray freeze drying","volume":"34","author":"Aziz","year":"2023","journal-title":"Adv. Powder Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123070","article-title":"Drug combinations for inhalation: current products and future development addressing disease control and patient compliance","volume":"643","author":"Banat","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0007","article-title":"A novel combined dry powder inhaler comprising nanosized ketoprofen-embedded mannitol-coated microparticles for pulmonary inflammations: development","volume":"17","author":"Banat","year":"2024"},{"key":"10.1016\/j.ejps.2025.107109_bib0008","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","article-title":"Theophylline","volume":"188","author":"Barnes","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejps.2025.107109_bib0009","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/pharmaceutics12060535","article-title":"Development of an innovative, carrier-based dry powder inhalation formulation containing spray-dried meloxicam potassium to improve the In vitro and In Silico aerodynamic properties","volume":"12","author":"Benke","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0010","first-page":"471","article-title":"The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride","volume":"16","author":"Benke","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0011","series-title":"Food Process Engineering and Technology, Food Science and Technology","first-page":"153","article-title":"Chapter 6 - size reduction","author":"Berk","year":"2009"},{"key":"10.1016\/j.ejps.2025.107109_bib0012","series-title":"Pharmacology for Pharmacy and the Health Sciences: a Patient-centred Approach","author":"Boarder","year":"2017"},{"key":"10.1016\/j.ejps.2025.107109_bib0013","first-page":"1","article-title":"Inhaled therapy in Respiratory disease: the complex interplay of pulmonary kinetic processes","volume":"2018","author":"Borghardt","year":"2018","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.ejps.2025.107109_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(00)00362-X","article-title":"Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance","volume":"70","author":"Bosquillon","year":"2001","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2025.107109_bib0015","article-title":"Development and characterization of PLA nanoparticles for pulmonary drug delivery: co-encapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug","volume":"53","author":"Buhecha","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2011.02.012","article-title":"New insights into respirable protein powder preparation using a nano spray dryer","volume":"408","author":"B\u00fcrki","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0017","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s11095-022-03363-2","article-title":"Advancements in particle engineering for inhalation delivery of small molecules and biotherapeutics","volume":"39","author":"Chang","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0018","first-page":"162","article-title":"Effect of powder polydispersity on aerosol generation","volume":"5","author":"Chew","year":"2002","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.ejps.2025.107109_bib0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpharm.2019.01.034","article-title":"Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery","volume":"559","author":"Chvatal","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/thx.2008.103432","article-title":"Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD","volume":"64","author":"Cosio","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.ejps.2025.107109_bib0021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2017.11.005","article-title":"Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs","volume":"269","author":"Davis","year":"2018","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2025.107109_bib0022","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1208\/s12249-021-02043-5","article-title":"Spray-dried inhalable powder formulations of therapeutic proteins and peptides","volume":"22","author":"Eedara","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107109_bib0023","series-title":"Preparations for Inhalation: Aerodynamic Assessment of Fine Particles","first-page":"354","year":"2019"},{"key":"10.1016\/j.ejps.2025.107109_bib0024","series-title":"Bulk Density Powders","year":"2024"},{"key":"10.1016\/j.ejps.2025.107109_bib0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejps.2016.08.036","article-title":"Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort\u00ae Turbuhaler\u00ae dry powder fixed combination aerosol drug","volume":"93","author":"Farkas","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0026","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2017.09.057","article-title":"Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler\u00ae dry powder inhaler","volume":"533","author":"Farkas","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rmed.2019.06.021","article-title":"Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection","volume":"154","author":"Farkas","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejps.2025.107109_bib0028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/excr.1998.4172","article-title":"Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism","volume":"243","author":"Foster","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00181","article-title":"Measurements of deposition, lung surface area and lung fluid for simulation of inhaled compounds","volume":"7","author":"Fr\u00f6hlich","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107109_bib0030","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612822666160128145356","article-title":"Large porous hollow particles: lightweight champions of pulmonary drug delivery","volume":"22","author":"Gharse","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2025.107109_bib0031","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/pharmaceutics13060809","article-title":"The development of an In vitro horizontal diffusion cell to monitor nasal powder penetration inline","volume":"13","author":"Gieszinger","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0032","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1208\/s12249-017-0884-0","article-title":"Effect of arginine on the aggregation of protein in freeze-dried formulations containing sugars and polyol: 1\u2014Formulation development","volume":"19","author":"Hackl","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107109_bib0033","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1208\/s12249-009-9313-3","article-title":"Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties","volume":"10","author":"Hassan","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107109_bib0034","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/jamp.2017.1396","article-title":"Harmonizing the nomenclature for therapeutic aerosol particle size: a proposal","volume":"31","author":"Hillyer","year":"2018","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107109_bib0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaerosci.2011.05.007","article-title":"Modelling inhaled particle deposition in the human lung\u2014a review","volume":"42","author":"Hofmann","year":"2011","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/s40199-024-00520-3","article-title":"Dry powder inhaler design and particle technology in enhancing pulmonary drug deposition: challenges and future strategies","author":"Islam","year":"2024","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0037","series-title":"Theophylline","author":"Jilani","year":"2024"},{"key":"10.1016\/j.ejps.2025.107109_bib0038","doi-asserted-by":"crossref","first-page":"rbac099","DOI":"10.1093\/rb\/rbac099","article-title":"Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations","volume":"10","author":"Knap","year":"2023","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.ejps.2025.107109_bib0039","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0021-8502(90)90121-D","article-title":"Monte Carlo modeling of aerosol deposition in human lungs. Part I: simulation of particle transport in a stochastic lung structure","volume":"21","author":"Koblinger","year":"1990","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0040","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/pharmaceutics15112523","article-title":"Caco-2 cell line standardization with pharmaceutical requirements and In vitro model suitability for permeability assays","volume":"15","author":"Kus","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0041","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107109_bib0042","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2125.2003.01893.x","article-title":"Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107109_bib0043","first-page":"528","article-title":"Optimizing aerosolization of a high-dose l-arginine powder for pulmonary delivery","volume":"10","author":"Lakio","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0044","first-page":"54","article-title":"Defining the \u2018dose\u2019for dry powder inhalers: the challenge of correlating In-vitro dose delivery results with clinical efficacy","volume":"20","author":"Lewis","year":"2017","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.ejps.2025.107109_bib0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijpharm.2017.07.033","article-title":"Investigation of l-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation","volume":"530","author":"Li","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0046","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2016.02.010","article-title":"l -leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders","volume":"102","author":"Li","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0047","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1023\/B:PHAM.0000008038.38378.d6","article-title":"In vitro simulation of solid-solid dehydration, rehydration, and solidification of trehalose dihydrate using thermal and vibrational spectroscopic techniques","volume":"20","author":"Lin","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0048","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1019966529819","article-title":"Thermal, FTIR and XRD study on some 1:1 molecular compounds of theophylline","volume":"69","author":"Madar\u00e1sz","year":"2002","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejps.2025.107109_bib0049","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejpb.2019.09.014","article-title":"The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes","volume":"144","author":"Mah","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijpharm.2016.06.032","article-title":"Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: the influence of mannitol as a co-milling agent","volume":"514","author":"Malamatari","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0051","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11095-017-2334-9","article-title":"Physico-chemical properties, aerosolization and dissolution of Co-spray dried azithromycin particles with l-leucine for inhalation","volume":"35","author":"Mangal","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0052","article-title":"Pulmonary vaccine delivery: an emerging strategy for vaccination and immunotherapy","volume":"69","author":"Masjedi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0053","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejpb.2004.10.002","article-title":"Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer","volume":"59","author":"Maury","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0054","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.2147\/IJN.S211182","article-title":"Rifampicin-carbohydrate spray-dried nanocomposite: a futuristic multiparticulate platform for pulmonary delivery","volume":"14","author":"Mehanna","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2025.107109_bib0055","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2017\/23626.9732","article-title":"Inhaled insulin - current direction of insulin research","author":"Mohanty","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0056","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-5173(95)00033-F","article-title":"The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs","volume":"122","author":"Mosharraf","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0057","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.ijbiomac.2020.10.192","article-title":"Aerodynamic properties and in silico deposition of isoniazid loaded chitosan\/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment","volume":"165","author":"Mukhtar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2025.107109_bib0058","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.anai.2016.05.006","article-title":"Inhalation devices, delivery systems, and patient technique","volume":"117","author":"Nelson","year":"2016","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"10.1016\/j.ejps.2025.107109_bib0059","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/jamp.2021.29056.spn","article-title":"Fine particle fraction: the good and the bad","volume":"35","author":"Newman","year":"2022","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107109_bib0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/07373930701438865","article-title":"Effect of drying methods on crystal transformation of trehalose","volume":"25","author":"Ohashi","year":"2007","journal-title":"Dry. Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120102","article-title":"On the particle formation of leucine in spray drying of inhalable microparticles","volume":"592","author":"Ordoubadi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103729","article-title":"Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis","volume":"28","author":"Parihar","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2025.107109_bib0063","series-title":"Respirable Microparticles of Aminoglycoside Antibiotics for Pulmonary Administration","author":"Parlati","year":"2009"},{"key":"10.1016\/j.ejps.2025.107109_bib0064","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/pharmaceutics13020211","article-title":"Formulation and In vitro and In silico characterization of \u201cnano-in-micro\u201d dry powder inhalers containing meloxicam","volume":"13","author":"Party","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/pharmaceutics15020545","article-title":"Preparation and characterization of Ibuprofen containing nano-embedded-microparticles for pulmonary delivery","volume":"15","author":"Party","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106247","article-title":"Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: in vitro aerodynamic and cell line measurements","volume":"176","author":"Party","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040466","article-title":"Optimization, In Vitro, and In Silico characterization of theophylline inhalable powder using raffinose-amino acid combination as fine co-spray-dried carriers","volume":"17","author":"Party","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124248","article-title":"A review on micro and nanoengineering in powder-based pulmonary drug delivery","volume":"659","author":"Pasero","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0069","series-title":"European Pharmacopeia","article-title":"Dissolution test for solid dosage forms","year":"2023"},{"key":"10.1016\/j.ejps.2025.107109_bib0070","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijpharm.2014.12.009","article-title":"Pulmonary drug delivery systems for tuberculosis treatment","volume":"478","author":"Pham","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0071","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/pulp.1994.1027","article-title":"Effect of theophylline administered intratracheally as a dry powder formulation on bronchospasm and airway microvascular leakage in the anaesthetized Guinea-pig","volume":"7","author":"Raeburn","year":"1994","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107109_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118689","article-title":"Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis","volume":"570","author":"Rangnekar","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0073","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1021\/es5000353","article-title":"Effective density and mixing State of aerosol particles in a near-traffic urban environment","volume":"48","author":"Rissler","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0074","series-title":"Dissolution Testing of Powders for Inhalation","author":"May","year":"2013"},{"key":"10.1016\/j.ejps.2025.107109_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-019-00648-9","article-title":"Spray drying as an advantageous strategy for enhancing pharmaceuticals bioavailability","volume":"10","author":"Salama","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107109_bib0076","article-title":"Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler","volume":"311","author":"Salem","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2025.107109_bib0077","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/jamp.2023.0029","article-title":"Different carriers for use in dry powder inhalers: characteristics of their particles","volume":"37","author":"Sal\u00fastio","year":"2024","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107109_bib0078","first-page":"1","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.ejps.2025.107109_bib0079","article-title":"A comprehensive overview of dry powder inhalers for pulmonary drug delivery: challenges, advances, optimization techniques, and applications","volume":"84","author":"Shahin","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s41030-017-0046-2","article-title":"Improving the efficiency of respiratory drug delivery: a review of current treatment trends and future strategies for asthma and chronic obstructive pulmonary disease","volume":"3","author":"Shakshuki","year":"2017","journal-title":"Pulm. Ther."},{"key":"10.1016\/j.ejps.2025.107109_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.02.014","article-title":"Prospects of formulating proteins\/peptides as aerosols for pulmonary drug delivery","volume":"314","author":"Shoyele","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0082","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2016.01.066","article-title":"Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate","volume":"501","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0083","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jamp.2016.1297","article-title":"The history of therapeutic aerosols: a chronological review","volume":"30","author":"Stein","year":"2017","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107109_bib0084","series-title":"Carbohydrates: The Essential Molecules of Life","first-page":"321","article-title":"Disaccharides, oligosaccharides and polysaccharides","author":"Stick","year":"2009"},{"key":"10.1016\/j.ejps.2025.107109_bib0085","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(94)90127-9","article-title":"Anti-inflammatory effects of low-dose oral theophylline in atopic asthma","volume":"343","author":"Sullivan","year":"1994","journal-title":"The Lancet"},{"key":"10.1016\/j.ejps.2025.107109_bib0086","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1208\/s12249-024-02900-z","article-title":"Quality by design in pulmonary drug delivery: a review on dry powder inhaler development, nanotherapy approaches, and regulatory considerations","volume":"25","author":"Sutar","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107109_bib0087","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2018.08.035","article-title":"Development of a new formulation of roflumilast for pulmonary drug delivery to treat inflammatory lung conditions","volume":"550","author":"Suzuki","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0088","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1021\/acs.langmuir.4c00909","article-title":"A review on investigating the interactions between nanoparticles and the pulmonary surfactant monolayer with coarse-grained molecular dynamics method","volume":"40","author":"Tang","year":"2024","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2025.107109_bib0089","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.powtec.2004.08.003","article-title":"Comparison of different flowability tests for powders for inhalation","volume":"146","author":"Thalberg","year":"2004","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejps.2025.107109_bib0091","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2008.01.028","article-title":"Comparative diffusion of drugs through bronchial tissue","volume":"357","author":"Van Zyl","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0092","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/ajrccm\/147.3.518","article-title":"Theophylline\u2014An immunomodulatory role in asthma?","volume":"147","author":"Ward","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejps.2025.107109_bib0093","series-title":"WHO Guideline on Biopharmaceutics Classification System -Based Biowaivers, Vol. Working document QAS\/23.929","year":"2023"},{"key":"10.1016\/j.ejps.2025.107109_bib0094","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/pharmaceutics14020300","article-title":"Rational development of a carrier-free dry powder inhalation formulation for Respiratory viral infections via quality by design: a drug-drug cocrystal of favipiravir and theophylline","volume":"14","author":"Wong","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107109_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121758","article-title":"Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles","volume":"621","author":"Xu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0096","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0097","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1211\/jpp.59.7.0003","article-title":"Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method","volume":"59","author":"You","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107109_bib0098","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2017.06.023","article-title":"Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders","volume":"119","author":"Yu","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0099","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2006.09.048","article-title":"Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers","volume":"333","author":"Zeng","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107109_bib0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejps.2015.04.016","article-title":"The formulation of a pressurized metered dose inhaler containing theophylline for inhalation","volume":"76","author":"Zhu","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107109_bib0101","first-page":"520","article-title":"Delivery of theophylline as dry powder for inhalation","volume":"10","author":"Zhu","year":"2015","journal-title":"Asian J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:09:19Z","timestamp":1760227759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":100,"alternative-id":["S0928098725001083"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107109","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced pulmonary delivery of spray-dried theophylline: investigation of the trehalose and amino acid combinations as innovative fine carriers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107109"}}